experimental group:carrelizumab combined with radiotherapy and chemotherapy

2 trials

Sponsors

Tianjin Medical University Cancer Institute and Hospital, He'nan Tumor Hospital

Conditions

Cervical cancercervical cancer

Phase 2

A single-arm, single-center, open, prospective phase II clinical study of carrelizumab combined with radiotherapy and chemotherapy for the treatment of recurrent or metastatic cervical cancer

RecruitingChiCTR2000041564

Tianjin Medical University Cancer Institute and HospitalCervical cancer

Start: 2021-01-01Updated: 2021-03-15

Phase 4

Phase II Clinical Study of Camrelizumab Combined with Radiotherapy and Chemotherapy in the Treatment of Locally Advanced Cervical Cancer

RecruitingChiCTR2100046760

He'nan Tumor Hospitalcervical cancer

Start: 2021-01-29Updated: 2022-06-20